☆ 4.8 Article

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Lewis Au et al.

Summary: The ADAPTeR study aimed to investigate the mechanism of therapeutic response to nivolumab in metastatic clear cell renal cell carcinoma, with genomic analysis showing no correlation between tumor molecular features and response. Pre-existing immunity may play a key role in predicting clinical response.

CANCER CELL (2021)

Add to Collection

Review Oncology

Radiogenomics in Interventional Oncology

Amgad M. Moussa et al.

Summary: Radiogenomics is a rapidly growing field with wide applications in oncology. Future applications, particularly in interventional oncology, will realize its full potential.

CURRENT ONCOLOGY REPORTS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Siyuan Dai et al.

Summary: This study revealed the unfavorable clinical outcomes of CXCL13(+)CD8(+)T cells in patients with ccRCC and their impairment of the immune function of total CD8(+)T cells. In addition, CXCL13(+)CD8(+)T cells also showed increased exhausted markers, decreased effector molecules, and better proliferation ability, associated with an immunoevasive tumor microenvironment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Review Oncology

Radiogenomics in Colorectal Cancer

Bogdan Badic et al.

Summary: Colorectal carcinoma is characterized by intratumoral heterogeneity that can be assessed by radiogenomics, which combines high-throughput quantitative data from medical imaging with molecular analysis. This approach is expected to advance personalized medicine but is still in its early stages with many challenges to overcome. The integration of image-derived features-radiomics and genomic profiles-genomics is a rapidly evolving field known as radiogenomics, with various studies dedicated to colorectal cancer showing potential for enhancing clinical decision-making.

CANCERS (2021)

Add to Collection

Article Oncology

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Chirag Krishna et al.

Summary: Clear cell renal cell carcinomas (ccRCCs) are highly immune infiltrated, and this study investigates the immune landscape of ccRCC using paired single-cell RNA (scRNA) and T cell receptor (TCR) sequencing, revealing extensive heterogeneity within and between patients. The study shows that tissue-resident T cells and tumor-associated macrophages (TAMs) are associated with responses to immune checkpoint blockade (ICB) and targeted therapies, highlighting the importance of cellular programs in therapeutic efficacy for ccRCC.

CANCER CELL (2021)

Add to Collection

Article Immunology

Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients

Yiliang Meng et al.

Summary: This study utilized single-cell RNA sequencing to explore the subpopulation distribution of neutrophils in a healthy kidney and ccRCC, revealing different functional characteristics in these two environments. Neutrophils in ccRCC may exhibit resistance to immune therapies, suggesting potential challenges in using these treatments for this type of renal cancer.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Add to Collection

Article Oncology

Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma

Kaili Chang et al.

Summary: A study on the expression data of ferroptosis-related genes in clear-cell renal cell carcinoma (ccRCC) revealed that a prognostic signature constructed by 11 ferroptosis genes was significantly related to overall survival and could predict prognosis accurately. The signature was found to be an independent prognostic factor and provide valuable insights for individualized treatment of ccRCC patients.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Urology & Nephrology

Radiomics for Renal Cell Carcinoma: Predicting Outcomes from Immunotherapy and Targeted Therapies-A Narrative Review

Kathrine S. Rallis et al.

Summary: Radiomics analysis can predict survival, treatment response, and disease progression in RCC patients receiving targeted therapies. Further large-scale studies are needed to validate these findings before clinical application.

EUROPEAN UROLOGY FOCUS (2021)

Add to Collection

Editorial Material Oncology

Tumor heterogeneity

Dana Pe'er et al.

Summary: Tumor heterogeneity has expanded beyond genetic terms and now encompasses multiple facets. These facets pose a challenge in understanding cancer etiology, but also present an opportunity to comprehend prognosis and therapy response.

CANCER CELL (2021)

Add to Collection

Review Oncology

Clinical and therapeutic relevance of cancer-associated fibroblasts

Yang Chen et al.

Summary: CAFs, as highly versatile and resilient cells in primary and metastatic tumors, play crucial roles in cancer progression through complex interactions with other cell types in the tumor microenvironment. Their heterogeneity and dynamic interactions are key factors in cancer development.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Review Urology & Nephrology

Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives

William C. Huang et al.

JOURNAL OF UROLOGY (2020)

Add to Collection

Review Urology & Nephrology

Oncometabolites in renal cancer

Cissy Yong et al.

NATURE REVIEWS NEPHROLOGY (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma-a systematic review and meta-analysis

Stephan Ursprung et al.

EUROPEAN RADIOLOGY (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Introduction to Radiomics

Marius E. Mayerhoefer et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Add to Collection

Review Oncology

Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature

Rodrigo Suarez-Ibarrola et al.

CANCERS (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Radiomics in medical imaging-how-to guide and critical reflection

Janita E. van Timmeren et al.

INSIGHTS INTO IMAGING (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

Robert J. Motzer et al.

NATURE MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting the HIF2-VEGF axis in renal cell carcinoma

Toni K. Choueiri et al.

NATURE MEDICINE (2020)

Add to Collection

Review Oncology

Radiomics of Liver Metastases: A Systematic Review

Francesco Fiz et al.

CANCERS (2020)

Add to Collection

Article Oncology

Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma

Rui Peng et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Add to Collection

Article Genetics & Heredity

Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma

Chao-Liang Xu et al.

FRONTIERS IN GENETICS (2020)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

David J. Clark et al.

CELL (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Turning foes to friends: targeting cancer-associated fibroblasts

Xueman Chen et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Samra Turajlic et al.

CELL (2018)

Add to Collection

Article Multidisciplinary Sciences

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Diana Miao et al.

SCIENCE (2018)

Add to Collection

Review Urology & Nephrology

Metabolic reprogramming in clear cell renal cell carcinoma

Hiromi I. Wettersten et al.

NATURE REVIEWS NEPHROLOGY (2017)

Add to Collection

Review Urology & Nephrology

Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

Johannes Schoedel et al.

EUROPEAN UROLOGY (2016)

Add to Collection

Review Oncology

VHL, the story of a tumour suppressor gene

Lucy Gossage et al.

NATURE REVIEWS CANCER (2015)

Add to Collection

Article Oncology

Neoadjuvant Sorafenib Treatment of Clear Cell Renal Cell Carcinoma and Release of Circulating Tumor Fragments

Gursah Kats-Ugurlu et al.

NEOPLASIA (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.